Definitive Healthcare (NASDAQ:DH) Updates Q2 2024 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its second quarter 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.080-0.090 for the period, compared to the consensus estimate of 0.090. The company issued revenue guidance of $62.0 million-$63.5 million, compared to the consensus revenue estimate of $65.2 million. Definitive Healthcare also updated its FY 2024 guidance to 0.360-0.380 EPS.

Wall Street Analyst Weigh In

Several brokerages have commented on DH. Canaccord Genuity Group raised their price objective on Definitive Healthcare from $9.00 to $10.00 and gave the company a hold rating in a report on Thursday, February 29th. Barclays raised their price objective on Definitive Healthcare from $10.00 to $11.00 and gave the company an equal weight rating in a report on Friday, March 1st. Morgan Stanley lowered Definitive Healthcare from an overweight rating to an equal weight rating and lowered their price target for the stock from $11.50 to $9.00 in a research note on Wednesday. Needham & Company LLC lowered Definitive Healthcare from a buy rating to a hold rating in a research note on Wednesday, January 17th. Finally, Stifel Nicolaus lowered their price target on Definitive Healthcare from $12.00 to $11.00 and set a buy rating on the stock in a research note on Wednesday, January 17th. Eight analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of Hold and a consensus price target of $11.25.

Definitive Healthcare Stock Performance

NASDAQ DH opened at $7.25 on Wednesday. The stock’s fifty day moving average is $7.78 and its two-hundred day moving average is $8.31. The firm has a market capitalization of $853.98 million, a P/E ratio of -4.07, a price-to-earnings-growth ratio of 6.12 and a beta of 1.41. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. Definitive Healthcare has a fifty-two week low of $5.53 and a fifty-two week high of $12.45.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). The company had revenue of $65.93 million for the quarter, compared to analyst estimates of $66.01 million. Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. On average, research analysts anticipate that Definitive Healthcare will post 0.11 earnings per share for the current year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.